Lysosome membrane stabilization in vivo: effects of steroidal and nonsteroidal anti-inflammatory drugs on the integrity of rat liver lysosomes.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D002744:Chlorpheniramine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D011431:Dextropropoxyphene / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D005959:Glucosidases / Q000032:analysis; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000187:drug effects*; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology; D008528:Mefenamic Acid / Q000494:pharmacology; D008566:Membranes / Q000187:drug effects; D009996:Osmotic Fragility / Q000187:drug effects; D010113:Oxyphenbutazone / Q000494:pharmacology; D010248:Paramethasone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D013256:Steroids / Q000494:pharmacology*; D014801:Vitamin A / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D013256:Steroids; D014801:Vitamin A; D008528:Mefenamic Acid; D002744:Chlorpheniramine; D005439:Flufenamic Acid; D003520:Cyclophosphamide; D005959:Glucosidases; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D011431:Dextropropoxyphene; D002746:Chlorpromazine; D010248:Paramethasone; D006854:Hydrocortisone; D007213:Indomethacin